News on companies and Pharmaceuticals

Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?

Read on: Independent

Swiss drugmaker Novartis to invest $23bn in US manufacturing and RD

Read on: Financial Times

Japan's Marubeni to buy Sumitomo Pharma's Asia business for $300m

Read on: Nikkei

Hetero founder warns of US tariff threat to Indian pharma industry

Read on: Times of India

Johnson & Johnson is the latest pharma giant to court Trump with new investment plans

Read on: Quartz

Warren calls on Oz to sever financial ties to health care, pharmaceutical companies

Read on: The Hill

Sun Pharma to acquire US oncology company for over Rs 3,000 crore

Read on: Times of India

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Read on: Quartz

Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil

Read on: The Washington Post

Drug makers including Pfizer are starting to sell drugs directly to consumers

Read on: NPR

Drug makers including Pfizer are starting to sell drugs directly to consumers

Read on: NPR

Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit

Read on: CNBC News

Zepbound sales soar, Ozempic sales miss, and CVS shakes up its leadership: Pharma news round up

Read on: Quartz

Amazon CEO: Drug store theft problems drive customers to our pharmacy business

Read on: Axios

Walgreens stock plunges as drugstore chain slashes profit guidance in 'challenging' consumer environment

Read on: CNBC News

Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how

Read on: Quartz

Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up

Read on: Quartz

Amazon hopes anti-obesity drug demand will boost pharmacy business

Read on: Financial Times

Hong Kong to promote collaboration with institutions and pharmaceutical firms to boost city as clinical trial and research centre

Read on: SCMP

Healthcare investor looks to cash in on pharma outsourcing trend with EUR1bn-plus sale

Read on: Financial Times

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Read on: CNBC News

Eli Lilly's direct drug sales alone may not upend the industry, but others could follow suit

Read on: CNBC News